Overview

Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Determine the influence of renal impairment on the pharmacokinetics and metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) 20 mg capsules
Phase:
Phase 1
Details
Lead Sponsor:
Zogenix, Inc.
Treatments:
Hydrocodone